Aegon NV (NYSE: AEG) and Aflac (NYSE:AFL) are both large-cap finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, institutional ownership, valuation, earnings and profitability.
This table compares Aegon NV and Aflac’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
This is a summary of current ratings and price targets for Aegon NV and Aflac, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Aegon NV presently has a consensus target price of $5.00, suggesting a potential downside of 14.82%. Aflac has a consensus target price of $75.56, suggesting a potential downside of 8.13%. Given Aflac’s higher probable upside, analysts plainly believe Aflac is more favorable than Aegon NV.
Aegon NV pays an annual dividend of $0.25 per share and has a dividend yield of 4.3%. Aflac pays an annual dividend of $1.72 per share and has a dividend yield of 2.1%. Aegon NV pays out 27.5% of its earnings in the form of a dividend. Aflac pays out 25.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Aflac has raised its dividend for 34 consecutive years.
Insider & Institutional Ownership
10.6% of Aegon NV shares are held by institutional investors. Comparatively, 65.7% of Aflac shares are held by institutional investors. 3.0% of Aflac shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Risk and Volatility
Aegon NV has a beta of 1.35, suggesting that its share price is 35% more volatile than the S&P 500. Comparatively, Aflac has a beta of 0.97, suggesting that its share price is 3% less volatile than the S&P 500.
Valuation and Earnings
This table compares Aegon NV and Aflac’s revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|Aegon NV||$62.30 billion||0.19||$3.13 billion||$0.91||6.45|
|Aflac||$22.65 billion||1.44||$4.75 billion||$6.63||12.40|
Aflac has higher revenue, but lower earnings than Aegon NV. Aegon NV is trading at a lower price-to-earnings ratio than Aflac, indicating that it is currently the more affordable of the two stocks.
Aflac beats Aegon NV on 12 of the 16 factors compared between the two stocks.
Aegon NV Company Profile
Aegon N.V. (Aegon) is an international life insurance, pensions and asset management company. The Company’s segments include the Americas, which includes the United States, Mexico and Brazil; the Netherlands; the United Kingdom; Central & Eastern Europe; Spain & Portugal; Asia, and Aegon Asset Management. It offers protection against mortality, morbidity and longevity risks, including traditional and universal life. It offers products with mortality, morbidity, and longevity risks, including traditional and universal life; mortgages; annuity products, and banking products. It offers individual protection products, such as annuities, term insurance, income protection and international/offshore bonds. It has activities in the Czech Republic, Hungary, Poland, Romania, Slovakia and Turkey. It offers life insurance marketed to high-net-worth individuals in Hong Kong and Singapore. It also offers investment products covering third-party customers, insurance-linked solutions.
Aflac Company Profile
Aflac Incorporated is a business holding company. The Company is involved in supplemental health and life insurance, which is marketed and administered through its subsidiary, American Family Life Assurance Company of Columbus (Aflac). The Company’s insurance business consists of two segments: Aflac Japan and Aflac U.S. The Company designs the United States insurance products to provide supplemental coverage for people having medical or primary insurance coverage. Aflac U.S. offers accident coverage on both an individual and group basis. The Company offers cancer plans, critical illness plans, and critical care and recovery plans. The Company designs the United States insurance products to provide supplemental coverage for people having medical or primary insurance coverage. Aflac U.S. offers accident coverage on both an individual and group basis. The Company offers cancer plans, critical illness plans, and critical care and recovery plans.
Receive News & Ratings for Aegon NV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aegon NV and related companies with MarketBeat.com's FREE daily email newsletter.